Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
NSTG [NASD]
NanoString Technologies, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.66 Insider Own0.60% Shs Outstand44.07M Perf Week10.20%
Market Cap3.22B Forward P/E- EPS next Y-2.13 Insider Trans-36.65% Shs Float43.82M Perf Month5.54%
Income-63.10M PEG- EPS next Q-0.51 Inst Own97.10% Short Float7.91% Perf Quarter89.81%
Sales118.00M P/S27.25 EPS this Y57.60% Inst Trans0.12% Short Ratio5.12 Perf Half Y106.08%
Book/sh2.69 P/B27.07 EPS next Y22.50% ROA-19.40% Target Price65.50 Perf Year140.68%
Cash/sh5.23 P/C13.91 EPS next 5Y- ROE-55.30% 52W Range13.85 - 78.68 Perf YTD8.90%
Dividend- P/FCF- EPS past 5Y15.90% ROI-18.50% 52W High-9.68% Beta1.78
Dividend %- Quick Ratio8.10 Sales past 5Y21.40% Gross Margin57.20% 52W Low413.07% ATR4.87
Employees551 Current Ratio8.90 Sales Q/Q3.90% Oper. Margin-42.40% RSI (14)59.74 Volatility8.40% 6.94%
OptionableYes Debt/Eq1.66 EPS Q/Q12.50% Profit Margin-53.50% Rel Volume1.09 Prev Close72.83
ShortableYes LT Debt/Eq1.66 EarningsNov 09 AMC Payout- Avg Volume676.79K Price71.06
Recom1.80 SMA203.14% SMA5021.68% SMA20073.52% Volume736,880 Change-2.43%
Jan-06-21Upgrade Cowen Market Perform → Outperform $75
Sep-09-20Initiated Morgan Stanley Equal-Weight $43
Nov-15-19Initiated Stifel Buy
Oct-09-18Initiated UBS Buy
Oct-12-17Downgrade Janney Buy → Neutral
Apr-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-11-13Upgrade Robert W. Baird Neutral → Outperform $12 → $18
Jan-10-21 03:00PM  
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020
Business Wire
Jan-06-21 12:14PM  
Nature Methods Selects Spatially-Resolved Transcriptomics as the Method of the Year for 2020
Business Wire
Jan-04-21 04:01PM  
NanoString to Present at the 39th Annual J.P. Morgan Healthcare Conference
Business Wire
Dec-18-20 08:51AM  
Is NSTG A Good Stock To Buy Now?
Insider Monkey
Dec-09-20 06:00AM  
NanoStrings GeoMx Digital Spatial Profiler Identifies Diverse Immune Responses Within COVID-19 Patients in Study Published in Nature Communications
Business Wire
Dec-01-20 06:00AM  
NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology
Business Wire +10.05%
Nov-18-20 04:01PM  
NanoString to Host Virtual Investor and Analyst Day on December 1st, 2020
Business Wire
Nov-17-20 06:00AM  
NanoString and Oregon Health & Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer
Business Wire +5.02%
Nov-12-20 04:01PM  
NanoString to Present at the Stifel 2020 Virtual Healthcare Conference
Business Wire +5.13%
06:47AM  
Here's What Analysts Are Forecasting For NanoString Technologies, Inc. (NASDAQ:NSTG) After Its Third-Quarter Results
Simply Wall St.
Nov-11-20 06:00AM  
NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC)
Business Wire +12.81%
Nov-09-20 05:25PM  
NanoString Technologies (NSTG) Reports Q3 Loss, Tops Revenue Estimates
Zacks
05:21PM  
NanoString Technologies: Q3 Earnings Insights
Benzinga
04:01PM  
NanoString Technologies Releases Operating Results for Third Quarter of 2020
Business Wire
06:00AM  
NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing
Business Wire
Nov-06-20 04:01PM  
NanoString to Present at the 29th Annual Credit Suisse Healthcare Conference
Business Wire
Nov-02-20 12:31PM  
Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know
Zacks
Oct-13-20 04:01PM  
NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
Business Wire
Oct-08-20 09:33AM  
OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users
Business Wire -5.20%
Oct-07-20 07:58PM  
NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock
Business Wire
Oct-06-20 04:18PM  
NanoString Technologies Announces Commencement of Public Offering of Common Stock
Business Wire
04:06PM  
NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020
Business Wire
Oct-05-20 06:00AM  
NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020
Business Wire
Sep-14-20 06:00AM  
NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites
Business Wire +6.51%
Sep-09-20 04:01PM  
NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
Business Wire
09:44AM  
Benzinga's Top Upgrades, Downgrades For September 9, 2020
Benzinga
06:00AM  
NanoString Announces New GeoMx COVID-19 Consortium, Part of the GeoMx Translational Leadership Network
Business Wire
Sep-03-20 04:01PM  
NanoString to Present at the 2020 Baird Global Healthcare Conference
Business Wire -7.56%
Aug-11-20 11:00AM  
Is NanoString Technologies (NASDAQ:NSTG) A Risky Investment?
Simply Wall St.
10:54AM  
Did You Miss NanoString Technologies' (NASDAQ:NSTG) Impressive 151% Share Price Gain?
Simply Wall St.
Aug-10-20 06:15PM  
NanoString Technologies (NSTG) Reports Q2 Loss, Tops Revenue Estimates
Zacks
04:01PM  
NanoString Technologies Releases Operating Results for Second Quarter of 2020
Business Wire
Aug-07-20 08:46AM  
Medical Products Stock Earnings on Aug 10: CGC, SDGR & More
Zacks
Aug-06-20 06:00AM  
NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler
Business Wire
06:00AM  
Bio-Techne And NanoString Announce Offering Of RNAscope Reagents Validated For Use With The GeoMx Digital Spatial Profiler
PR Newswire
Aug-05-20 05:49PM  
Were Hedge Funds Right About Buying NanoString Technologies Inc (NSTG)?
Insider Monkey
Aug-03-20 12:31PM  
Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know
Zacks
06:00AM  
NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers
Business Wire
Jul-08-20 06:00AM  
NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
Business Wire
Jul-02-20 08:39AM  
NanoString Technologies (NSTG) Surges: Stock Moves 10.3% Higher
Zacks +8.25%
Jun-23-20 11:06AM  
Hedge Funds Getting Crazy About NanoString Technologies Inc (NSTG)
Insider Monkey
Jun-17-20 05:05PM  
Edited Transcript of NSTG.OQ earnings conference call or presentation 7-May-20 8:30pm GMT
Thomson Reuters StreetEvents
Jun-16-20 05:41PM  
NanoString Announces New Products to Advance COVID-19 Disease Research
Business Wire
May-20-20 09:00AM  
NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data
Business Wire
May-19-20 09:37AM  
21 Risky Stocks That Might Have Borrowed More Than Is Good For Them
Barrons.com
May-14-20 04:00PM  
NanoString to Present at the UBS Global Healthcare Conference
Business Wire +5.23%
May-12-20 06:00AM  
Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research
Business Wire -7.95%
May-11-20 06:00AM  
NanoString to Present at the Bank of America Health Care Conference
Business Wire +7.12%
May-09-20 12:01PM  
Nanostring Technologies (NSTG) Q1 2020 Earnings Call Transcript
Motley Fool
May-07-20 06:35PM  
NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates
Zacks
04:01PM  
NanoString Technologies Releases Operating Results for First Quarter of 2020
Business Wire
Apr-15-20 09:00AM  
Singapore Researchers Use NanoStrings nCounter Platform to Rapidly Profile the Response of the Immune System to the SARS-CoV-2 Virus
Business Wire
Apr-07-20 06:34AM  
Downgrade: Here's How Analysts See NanoString Technologies, Inc. (NASDAQ:NSTG) Performing In The Near Term
Simply Wall St.
Apr-06-20 04:01PM  
NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020
Business Wire +6.87%
Mar-27-20 09:47AM  
Why NanoString Technologies (NSTG) Stock Might be a Great Pick
Zacks -11.44%
Mar-07-20 07:05AM  
Edited Transcript of NSTG earnings conference call or presentation 26-Feb-20 9:30pm GMT
Thomson Reuters StreetEvents
Mar-05-20 06:00AM  
NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes
Business Wire
Mar-04-20 07:21AM  
NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes
Business Wire
Mar-03-20 09:41AM  
Top Ranked Momentum Stocks to Buy for March 3rd
Zacks
Mar-02-20 06:05AM  
Will NanoString Technologies Continue to Surge Higher?
Zacks
Feb-28-20 09:44AM  
NanoString Technologies, Inc. Analysts Are Pretty Bullish On The Stock After Recent Results
Simply Wall St.
Feb-26-20 04:00PM  
NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook
Business Wire
Feb-20-20 06:00AM  
NanoString Highlights Groundbreaking Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology (AGBT) Conference
Business Wire
Feb-19-20 12:31PM  
NanoString Technologies (NSTG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks
Feb-18-20 06:00AM  
NanoString to Present at the 40th Annual Cowen Healthcare Conference
Business Wire
Feb-10-20 09:00AM  
NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020
Business Wire
Feb-06-20 08:00AM  
Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announces Research Collaboration with NanoString Technologies
GlobeNewswire
Jan-20-20 09:40AM  
Is NanoString Technologies (NASDAQ:NSTG) Weighed On By Its Debt Load?
Simply Wall St.
Jan-15-20 01:28PM  
Two Landmark Nature Publications use NanoStrings GeoMx Digital Spatial Profiling to Dissect Mechanisms of Response to Immunotherapy
Business Wire
Jan-12-20 06:00PM  
NanoString Provides Preliminary Operational and Financial Results for Fourth Quarter and FY 2019
Business Wire
Jan-02-20 04:01PM  
NanoString to Present at the 38th Annual JP Morgan Healthcare Conference
Business Wire
Dec-11-19 06:00AM  
NanoString Announces the Creation of the GeoMx Breast Cancer Consortium
Business Wire
Dec-10-19 02:25PM  
Here is What Hedge Funds Think About NanoString Technologies Inc (NSTG)
Insider Monkey
Dec-06-19 12:59PM  
Is NanoString Technologies, Inc.'s (NASDAQ:NSTG) CEO Paid At A Competitive Rate?
Simply Wall St.
Dec-03-19 06:05PM  
Peninsula diagnostics company's overseas plans could more than triple revenue
American City Business Journals
05:09PM  
$50M deal could expand NanoString Technologies diagnostic test into more markets
American City Business Journals
05:00PM  
NanoString Announces Exclusive License of nCounter Diagnostic Assets and Rights to Veracyte
Business Wire
06:00AM  
Nature Medicine Publication Highlights Use of NanoStrings Hyb & Seq Technology to Perform Rapid Genotypic and Phenotypic Antibiotic Susceptibility Testing
Business Wire
Nov-25-19 04:01PM  
NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference
TEST Business Wire Releases
04:01PM  
NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference
Business Wire
Nov-20-19 05:29PM  
Edited Transcript of NSTG earnings conference call or presentation 4-Nov-19 9:30pm GMT
Thomson Reuters StreetEvents
Nov-13-19 04:01PM  
NanoString to Present at the Stifel 2019 Healthcare Conference
Business Wire
Nov-07-19 04:01PM  
NanoString Highlights the Results of Research Presented at the 2019 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Business Wire
Nov-04-19 06:15PM  
NanoString Technologies (NSTG) Reports Q3 Loss, Tops Revenue Estimates
Zacks
04:01PM  
NanoString Technologies Releases Operating Results for Third Quarter of 2019
Business Wire
06:00AM  
NanoString Technologies Supports the Human Cell Atlas (HCA) to Enable High-plex Spatial Analysis Across Discovery Programs
Business Wire
06:00AM  
NanoString Announces Availability of the GeoMx Cancer Transcriptome Atlas Through the Technology Access Program for Digital Spatial Profiling
Business Wire
Oct-31-19 06:00AM  
NanoString Appoints Don Kania, Ph.D. to its Board of Directors
Business Wire
Oct-28-19 02:57PM  
Should You Avoid NanoString Technologies Inc (NSTG)?
Insider Monkey
10:32AM  
Analysts Estimate NanoString Technologies (NSTG) to Report a Decline in Earnings: What to Look Out for
Zacks
Oct-21-19 02:03PM  
One Thing To Remember About The NanoString Technologies, Inc. (NASDAQ:NSTG) Share Price
Simply Wall St.
Oct-07-19 04:05PM  
NanoString to Release Third Quarter 2019 Financial Results and Host Conference Call on Monday, November 4, 2019
Business Wire
Oct-04-19 04:30PM  
NanoString Reports Inducement Grant Under NASDAQ Listing Rules
Business Wire
Oct-02-19 06:00AM  
NanoString Appoints Mark Winham Senior Vice President of Operations
Business Wire
Sep-24-19 08:00AM  
CareDx Adds HistoMap To Testing Portfolio
GlobeNewswire -8.47%
Sep-23-19 06:00AM  
NanoString Introduces New Gene Expression Research Panel for Human Organ Transplantation
Business Wire
Sep-06-19 07:15AM  
The NanoString Technologies (NASDAQ:NSTG) Share Price Has Gained 87% And Shareholders Are Hoping For More
Simply Wall St.
Aug-28-19 06:00AM  
NanoString to Present at the 2019 Morgan Stanley Global Healthcare Conference
GlobeNewswire
Aug-21-19 11:57PM  
Edited Transcript of NSTG earnings conference call or presentation 31-Jul-19 8:30pm GMT
Thomson Reuters StreetEvents
Aug-19-19 06:00AM  
NanoString to Present at the Baird 2019 Global Healthcare Conference
GlobeNewswire
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and pan cancer and 360 gene expression, CAR-T characterization, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, miRNA expression, human organ transplant, human and mouse metabolic pathway, and human and mouse fibrosis panels. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq molecular profiling system to determine and analyze gene sequences within biological samples. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; Astellas Pharma, Inc.; and Oregon Health & Science University for the development of novel GeoMx Digital Spatial Profiler protein assays to spatially profile breast cancer. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Malloy KirkDirectorJan 11Option Exercise12.802,50032,0103,490Jan 13 04:36 PM
Malloy KirkDirectorJan 11Sale66.532,500166,325990Jan 13 04:36 PM
HERSHBERG ROBERTDirectorDec 15Option Exercise11.201,50016,8003,390Dec 16 04:17 PM
HERSHBERG ROBERTDirectorDec 15Sale69.331,500103,9941,890Dec 16 04:17 PM
Norden GregoryDirectorDec 07Option Exercise1.9210,40619,98012,296Dec 09 04:41 PM
WAITE CHARLES P JRDirectorDec 07Option Exercise18.8837,860714,71139,750Dec 09 04:40 PM
Norden GregoryDirectorDec 07Sale58.3210,406606,8921,890Dec 09 04:41 PM
WAITE CHARLES P JRDirectorDec 07Sale60.4737,8602,289,3801,890Dec 09 04:40 PM
Bailey K ThomasChief Financial OfficerNov 19Option Exercise23.3412,709296,62812,709Nov 20 04:56 PM
Bailey K ThomasChief Financial OfficerNov 19Sale47.3512,709601,7290Nov 20 04:56 PM
Bailey K ThomasChief Financial OfficerNov 18Option Exercise8.165,93748,4465,937Nov 20 04:56 PM
Bailey K ThomasChief Financial OfficerNov 18Sale48.215,937286,1970Nov 20 04:56 PM
HERSHBERG ROBERTDirectorNov 16Option Exercise11.201,50016,8003,390Nov 18 04:17 PM
BROWN J. CHADSVP, Sales & MarketingNov 16Option Exercise17.526,281110,0496,721Nov 18 04:18 PM
HERSHBERG ROBERTDirectorNov 16Sale46.671,50070,0021,890Nov 18 04:17 PM
BROWN J. CHADSVP, Sales & MarketingNov 16Sale46.216,281290,245440Nov 18 04:18 PM
Malloy KirkDirectorNov 09Option Exercise12.802,50032,0103,490Nov 12 05:00 PM
Malloy KirkDirectorNov 09Sale40.962,500102,400990Nov 12 05:00 PM
HERSHBERG ROBERTDirectorOct 15Option Exercise11.201,50016,8003,390Oct 16 04:44 PM
HERSHBERG ROBERTDirectorOct 15Sale39.351,50059,0191,890Oct 16 04:44 PM
HERSHBERG ROBERTDirectorSep 15Option Exercise11.201,50016,8003,390Sep 17 05:10 PM
HERSHBERG ROBERTDirectorSep 15Sale43.621,50065,4311,890Sep 17 05:10 PM
GRAY R BRADLEYPresident and CEOSep 09Option Exercise1.9237,95172,866149,637Sep 11 04:41 PM
GRAY R BRADLEYPresident and CEOSep 09Sale38.8537,9511,474,512111,686Sep 11 04:41 PM
Malloy KirkDirectorSep 08Option Exercise12.802,50032,0104,390Sep 11 04:41 PM
Malloy KirkDirectorSep 08Sale36.613,400124,474990Sep 11 04:41 PM
Bailey K ThomasChief Financial OfficerAug 18Option Exercise8.165,93848,4545,938Aug 20 04:46 PM
Bailey K ThomasChief Financial OfficerAug 18Sale38.945,938231,2290Aug 20 04:46 PM
HERSHBERG ROBERTDirectorAug 17Option Exercise11.201,50016,8003,390Aug 19 04:40 PM
HERSHBERG ROBERTDirectorAug 17Sale38.371,50057,5551,890Aug 19 04:40 PM
BROWN J. CHADSVP, Sales & MarketingAug 14Option Exercise17.526,281110,0496,448Aug 18 04:32 PM
BROWN J. CHADSVP, Sales & MarketingAug 14Sale38.056,281238,992167Aug 18 04:32 PM
Norden GregoryDirectorAug 13Sale38.8310,000388,2501,890Aug 13 06:43 PM
Malloy KirkDirectorAug 11Option Exercise12.802,50032,0104,390Aug 13 04:48 PM
Malloy KirkDirectorAug 11Sale35.972,50089,9251,890Aug 13 04:48 PM
HERSHBERG ROBERTDirectorJul 15Option Exercise11.201,50016,8003,390Jul 17 04:53 PM
HERSHBERG ROBERTDirectorJul 15Sale36.151,50054,2241,890Jul 17 04:53 PM
GRAY R BRADLEYPresident and CEOJul 06Option Exercise1.9240,00076,800142,903Jul 08 04:34 PM
GRAY R BRADLEYPresident and CEOJul 06Sale37.0340,0001,481,200102,903Jul 08 04:34 PM
Bailey K ThomasChief Financial OfficerJun 30Sale29.173,26095,1050Jul 02 04:35 PM
GRAY R BRADLEYPresident and CEOJun 19Option Exercise1.9213,63726,183116,540Jun 22 04:13 PM
GRAY R BRADLEYPresident and CEOJun 19Sale33.5813,637457,930102,903Jun 22 04:13 PM
GRAY R BRADLEYPresident and CEOJun 18Option Exercise1.926,36312,217109,266Jun 22 04:13 PM
GRAY R BRADLEYPresident and CEOJun 18Sale33.576,363213,606102,903Jun 22 04:13 PM
HERSHBERG ROBERTDirectorJun 15Option Exercise11.201,50016,8003,390Jun 17 07:45 PM
HERSHBERG ROBERTDirectorJun 15Sale30.791,50046,1861,890Jun 17 07:45 PM
BROWN J. CHADSVP, Sales & MarketingJun 01Option Exercise20.4512,635258,35134,879Jun 03 04:18 PM
BROWN J. CHADSVP, Sales & MarketingJun 01Sale30.8334,7121,070,133167Jun 03 04:18 PM
Bailey K ThomasChief Financial OfficerMay 18Option Exercise8.165,93748,4469,197May 20 04:16 PM
Bailey K ThomasChief Financial OfficerMay 18Sale31.865,937189,1303,260May 20 04:16 PM
HERSHBERG ROBERTDirectorMay 15Option Exercise7.4710,16875,95510,168May 18 06:13 PM
HERSHBERG ROBERTDirectorMay 15Sale30.8310,168313,4340May 18 06:13 PM
WAITE CHARLES P JRDirectorMay 14Option Exercise8.451,73414,6521,734May 18 06:13 PM
WAITE CHARLES P JRDirectorMay 14Sale30.171,73452,3150May 18 06:13 PM
WAITE CHARLES P JRDirectorMay 12Option Exercise8.456,09451,4946,094May 14 04:13 PM
WAITE CHARLES P JRDirectorMay 12Sale32.276,094196,6530May 14 04:13 PM
Malloy KirkDirectorApr 20Option Exercise16.361,50024,5401,500Apr 22 04:27 PM
Malloy KirkDirectorApr 20Sale30.001,50045,0000Apr 22 04:27 PM
Malloy KirkDirectorApr 15Option Exercise7.471,0007,4701,000Apr 17 04:12 PM
Malloy KirkDirectorApr 15Sale25.611,00025,6130Apr 17 04:12 PM
GRAY R BRADLEYPresident and CEOMar 16Option Exercise0.0021,9940111,558Mar 18 05:22 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevMar 16Option Exercise0.003,177071,577Mar 18 05:21 PM
Bailey K ThomasChief Financial OfficerMar 16Option Exercise0.005,37605,376Mar 18 05:21 PM
BROWN J. CHADSVP, Sales & MarketingMar 16Option Exercise0.005,376023,554Mar 18 05:22 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 16Option Exercise0.005,376057,982Mar 18 05:21 PM
Bailey K ThomasChief Financial OfficerMar 10Option Exercise8.167,91764,6037,917Mar 11 04:17 PM
Bailey K ThomasChief Financial OfficerMar 10Sale31.477,917249,1850Mar 11 04:17 PM
GRAY R BRADLEYPresident and CEOMar 09Option Exercise2.0942,04987,79098,673Mar 11 04:18 PM
GRAY R BRADLEYPresident and CEOMar 09Sale31.6242,0491,329,48056,624Mar 11 04:18 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevFeb 27Option Exercise12.5022,000275,00076,169Mar 02 04:05 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevFeb 27Sale35.0922,000771,99354,169Mar 02 04:05 PM
BROWN J. CHADSVP, Sales & MarketingFeb 18Option Exercise14.981,45821,84211,713Feb 18 05:18 PM
BROWN J. CHADSVP, Sales & MarketingFeb 18Sale33.511,45848,85810,255Feb 18 05:18 PM
BROWN J. CHADSVP, Sales & MarketingFeb 14Option Exercise12.286,10274,90916,357Feb 18 05:18 PM
GRAY R BRADLEYPresident and CEOFeb 14Option Exercise2.2420,00044,80070,050Feb 18 05:19 PM
BROWN J. CHADSVP, Sales & MarketingFeb 14Sale32.006,102195,26410,255Feb 18 05:18 PM
GRAY R BRADLEYPresident and CEOFeb 14Sale33.6320,000672,56450,050Feb 18 05:19 PM
BROWN J. CHADSVP, Sales & MarketingFeb 13Option Exercise16.358,801143,89619,056Feb 13 04:47 PM
Malloy KirkDirectorFeb 12Option Exercise12.802,50032,0101,500Feb 13 04:46 PM
Malloy KirkDirectorFeb 12Sale31.182,50077,9500Feb 13 04:46 PM
GRAY R BRADLEYPresident and CEOFeb 11Option Exercise2.2420,00044,80070,050Feb 13 04:47 PM
BROWN J. CHADSVP, Sales & MarketingFeb 11Option Exercise16.357,700125,89517,955Feb 13 04:47 PM
GRAY R BRADLEYPresident and CEOFeb 11Sale31.8720,000637,36850,050Feb 13 04:47 PM
BROWN J. CHADSVP, Sales & MarketingFeb 11Sale32.0016,501528,03210,255Feb 13 04:47 PM
Bailey K ThomasChief Financial OfficerFeb 03Sale28.1025,872727,0760Feb 05 04:15 PM
GRAY R BRADLEYPresident and CEOJan 21Option Exercise2.2420,00044,80070,050Jan 23 04:10 PM
GRAY R BRADLEYPresident and CEOJan 21Sale29.9920,000599,80450,050Jan 23 04:10 PM
Bailey K ThomasChief Financial OfficerJan 16Option Exercise0.0035,000035,000Jan 21 04:53 PM
open in yahoo | open in reuters | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.